A novel bioinformatics strategy to uncover the active ingredients and molecular mechanisms of Bai Shao in the treatment of non-alcoholic fatty liver disease

被引:0
|
作者
He, Shuaibing [1 ,2 ]
Chen, Hantao [1 ,2 ]
Yi, Yanfeng [3 ]
Hou, Diandong [1 ,2 ]
Fu, Xuyan [1 ,2 ]
Xie, Jinlu [1 ,2 ]
Zhang, Juan [4 ]
Liu, Chongbin [1 ,2 ]
Ru, Xiaochen [1 ,2 ]
Wang, Juan [5 ]
机构
[1] Huzhou Univ, Huzhou Cent Hosp, Sch Med, Key Lab Vector Biol & Pathogen Control Zhejiang Pr, Huzhou, Peoples R China
[2] Huzhou Univ, Key Lab Precise Prevent & Control Major Chron Dis, Huzhou, Peoples R China
[3] Huzhou Coll, Sch Sci & Engn, Dept Life Sci & Hlth, Huzhou, Peoples R China
[4] Xinjiang Inst Chinese Mat Med & Ethnodrug, Urumqi, Peoples R China
[5] Zhejiang Pharmaceut Univ, Sch Tradit Chinese Med, Ningbo, Peoples R China
基金
中国国家自然科学基金;
关键词
bioinformatics; Bai Shao; non-alcoholic fatty liver disease; Traditional Chinese Medicine; hepatoprotection; network pharmacology; active ingredient; molecular mechanism; ANIT-INDUCED CHOLESTASIS; TETRACHLORIDE-INDUCED HEPATOTOXICITY; TRADITIONAL CHINESE MEDICINE; NETWORK PHARMACOLOGY; HERBAL MEDICINES; TOTAL GLUCOSIDES; ACTIVATING NRF2; IN-VIVO; PROTECTS; APOPTOSIS;
D O I
10.3389/fphar.2024.1406188
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: As a new discipline, network pharmacology has been widely used to disclose the material basis and mechanism of Traditional Chinese Medicine in recent years. However, numerous researches indicated that the material basis of TCMs identified based on network pharmacology was the mixtures of beneficial and harmful substances rather than the real material basis. In this work, taking the anti-NAFLD (non-alcoholic fatty liver disease) effect of Bai Shao (BS) as a case, we attempted to propose a novel bioinformatics strategy to uncover the material basis and mechanism of TCMs in a precise manner.Methods: In our previous studies, we have done a lot work to explore TCM-induced hepatoprotection. Here, by integrating our previous studies, we developed a novel computational pharmacology method to identify hepatoprotective ingredients from TCMs. Then the developed method was used to discover the material basis and mechanism of Bai Shao against Non-alcoholic fatty liver disease by combining with the techniques of molecular network, microarray data analysis, molecular docking, and molecular dynamics simulation. Finally, literature verification method was utilized to validate the findings.Results: A total of 12 ingredients were found to be associated with the anti-NAFLD effect of BS, including monoterpene glucosides, flavonoids, triterpenes, and phenolic acids. Further analysis found that IL1-beta, IL6, and JUN would be the key targets. Interestingly, molecular docking and molecular dynamics simulation analysis showed that there indeed existed strong and stable binding affinity between the active ingredients and the key targets. In addition, a total of 23 NAFLD-related KEGG pathways were enriched. The major biological processes involved by these pathways including inflammation, apoptosis, lipid metabolism, and glucose metabolism. Of note, there was a great deal of evidence available in the literature to support the findings mentioned above, indicating that our method was reliable.Discussion: In summary, the contributions of this work can be summarized as two aspects as follows. Firstly, we systematically elucidated the material basis and mechanism of BS against NAFLD from multiple perspectives. These findings further enhanced the theoretical foundation of BS on NAFLD. Secondly, a novel computational pharmacology research strategy was proposed, which would assist network pharmacology to uncover the scientific connotation TCMs in a more precise manner.
引用
收藏
页数:25
相关论文
共 50 条
  • [1] Non-alcoholic fatty liver disease associated molecular mechanisms of hepatocarcinogenesis
    Li, Bei
    Lu, Jiong
    You, Zhen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 14 (04): : 1559 - 1568
  • [2] Chinese medicine in the treatment of non-alcoholic fatty liver disease based on network pharmacology: a review
    Zheng, Shihao
    Xue, Chengyuan
    Li, Size
    Zao, Xiaobin
    Li, Xiaoke
    Liu, Qiyao
    Cao, Xu
    Wang, Wei
    Qi, Wenying
    Zhang, Peng
    Ye, Yongan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [3] Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology
    Li, Si
    Wu, Xi
    Ma, Yue
    Zhang, Hua
    Chen, Wen
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 311
  • [4] Treatment of Non-Alcoholic Fatty Liver Disease
    Dyson, Jessica
    Day, Chris
    DIGESTIVE DISEASES, 2014, 32 (05) : 597 - 604
  • [5] Herbal medicine as a potential treatment for non-alcoholic fatty liver disease
    Nie, Wen-Yi
    Ye, Yang
    Tong, Hong-Xuan
    Hu, Jing-Qing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (09)
  • [6] Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment
    Chun-Yong Sun
    Le-Le Yang
    Pan Zhao
    Pei-Zheng Yan
    Jia Li
    Dong-Sheng Zhao
    Hereditas, 159
  • [7] Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment
    Sun, Chun-Yong
    Yang, Le-Le
    Zhao, Pan
    Yan, Pei-Zheng
    Li, Jia
    Zhao, Dong-Sheng
    HEREDITAS, 2022, 159 (01)
  • [8] Mechanism of Paeoniae Radix Alba in the Treatment of Non-alcoholic Fatty Liver Disease Based on Sequential Metabolites Identification Approach, Network Pharmacology, and Binding Affinity Measurement
    Luo, Zhiqiang
    Liu, Yang
    Han, Xing
    Yang, Wenning
    Wang, Guopeng
    Wang, Jing
    Jiang, Xiaoquan
    Sen, Muli
    Li, Xueyan
    Yu, Guohua
    Shi, Yuanyuan
    FRONTIERS IN NUTRITION, 2021, 8
  • [9] Molecular pathways in non-alcoholic fatty liver disease
    Berlanga, Alba
    Guiu-Jurado, Esther
    Antonio Porras, Jose
    Auguet, Teresa
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 221 - 238
  • [10] Investigation on the mechanism of Ginkgo Folium in the treatment of Non-alcoholic Fatty Liver Disease by strategy of network pharmacology and molecular docking
    Sun, Yuanfang
    Wang, Leqi
    Du, Lijing
    Yu, Huajun
    Tian, Yan
    Jin, Huizi
    Li, Shasha
    Yan, Shikai
    Xiao, Xue
    TECHNOLOGY AND HEALTH CARE, 2023, 31 : S209 - S221